CNS Pharmaceuticals, Inc. (CNSP)
4.97
+0.22
(+4.63%)
USD |
NASDAQ |
Oct 23, 16:00
4.97
0.00 (0.00%)
After-Hours: 20:00
CNS Pharmaceuticals EPS Diluted (Quarterly) : -0.3785 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3785 |
| March 31, 2026 | -7.302 |
| December 31, 2025 | -10.15 |
| September 30, 2025 | -5.759 |
| June 30, 2025 | -6.417 |
| March 31, 2025 | -1.578 |
| December 31, 2024 | -26.96 |
| September 30, 2024 | -0.2527 |
| June 30, 2024 | -6.719 |
| March 31, 2024 | -20.34 |
| December 31, 2023 | -47.70 |
| September 30, 2023 | -54.14 |
| June 30, 2023 | -51.86 |
| March 31, 2023 | -129.35 |
| December 31, 2022 | -191.06 |
| September 30, 2022 | -128.13 |
| June 30, 2022 | -133.62 |
| Date | Value |
|---|---|
| March 31, 2022 | -2.193M |
| December 31, 2021 | -88353.00 |
| September 30, 2021 | -208.48 |
| June 30, 2021 | -224.92 |
| March 31, 2021 | -219.75 |
| December 31, 2020 | -265.66 |
| September 30, 2020 | -183.00 |
| June 30, 2020 | -225.57 |
| March 31, 2020 | -179.46 |
| December 31, 2019 | -230.46 |
| September 30, 2019 | -64.44 |
| June 30, 2019 | -39.36 |
| March 31, 2019 | -19.29 |
| December 31, 2018 | -604.70 |
| September 30, 2018 | -17.61 |
| June 30, 2018 | -23.48 |
| March 31, 2018 | -28.24 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.588M |
| Total Expenses (Quarterly) | 2.588M |
| Enterprise Value | -12.72M |
| Earnings Yield | -474.7% |
| Normalized Earnings Yield | -474.68 |